BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37366430)

  • 1. Trajectories of Spirometric Patterns, Obstructive and PRISm, in a Population-Based Cohort in Latin America.
    Perez-Padilla R; Montes de Oca M; Thirion-Romero I; Wehrmeister FC; Lopez MV; Valdivia G; Jardim JR; Muino A; B Menezes AM;
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1277-1285. PubMed ID: 37366430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.
    Higbee DH; Granell R; Davey Smith G; Dodd JW
    Lancet Respir Med; 2022 Feb; 10(2):149-157. PubMed ID: 34739861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.
    Wijnant SRA; De Roos E; Kavousi M; Stricker BH; Terzikhan N; Lahousse L; Brusselle GG
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31601717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
    Wan ES; Hokanson JE; Regan EA; Young KA; Make BJ; DeMeo DL; Mason SE; San Jose Estepar R; Crapo JD; Silverman EK
    Chest; 2022 Mar; 161(3):651-661. PubMed ID: 34592319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study.
    Perez-Padilla R; Wehrmeister FC; Celli BR; Lopez-Varela MV; Montes de Oca M; Muiño A; Talamo C; Jardim JR; Valdivia G; Lisboa C; Menezes AM;
    PLoS One; 2013; 8(8):e67960. PubMed ID: 23936297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.
    Wan ES; Balte P; Schwartz JE; Bhatt SP; Cassano PA; Couper D; Daviglus ML; Dransfield MT; Gharib SA; Jacobs DR; Kalhan R; London SJ; Navas-Acien A; O'Connor GT; Sanders JL; Smith BM; White W; Yende S; Oelsner EC
    JAMA; 2021 Dec; 326(22):2287-2298. PubMed ID: 34905031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
    Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study.
    Park HJ; Byun MK; Rhee CK; Kim K; Kim HJ; Yoo KH
    Respir Res; 2018 Sep; 19(1):185. PubMed ID: 30249256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort.
    Perez-Padilla R; Wehrmeister FC; de Oca MM; Lopez MV; Jardim JR; Muiño A; Valdivia G; Menezes AMB
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3549-3561. PubMed ID: 30464437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
    Cadham CJ; Oh H; Han MK; Mannino D; Cook S; Meza R; Levy DT; Sánchez-Romero LM
    Respir Res; 2024 May; 25(1):208. PubMed ID: 38750492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Risks of Mortality and Longitudinal Transition Trajectories in New Potential Subtypes of the Preserved Ratio Impaired Spirometry: Evidence From the English Longitudinal Study of Aging.
    He D; Sun Y; Gao M; Wu Q; Cheng Z; Li J; Zhou Y; Ying K; Zhu Y
    Front Med (Lausanne); 2021; 8():755855. PubMed ID: 34859011
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.
    Wan ES; Fortis S; Regan EA; Hokanson J; Han MK; Casaburi R; Make BJ; Crapo JD; DeMeo DL; Silverman EK;
    Am J Respir Crit Care Med; 2018 Dec; 198(11):1397-1405. PubMed ID: 29874098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies.
    Sobrino E; Irazola VE; Gutierrez L; Chen CS; Lanas F; Calandrelli M; Ponzo J; Mores N; Serón P; Lee A; He J; Rubinstein AL
    BMC Pulm Med; 2017 Dec; 17(1):187. PubMed ID: 29228947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
    Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
    Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population.
    Lopez Varela MV; Montes de Oca M; Wehrmeister FC; Rodriguez C; Ramirez L; Menezes A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1901-1911. PubMed ID: 31692595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study.
    Casas Herrera A; Montes de Oca M; López Varela MV; Aguirre C; Schiavi E; Jardim JR;
    PLoS One; 2016; 11(4):e0152266. PubMed ID: 27073880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity.
    Zhao N; Wu F; Peng J; Zheng Y; Tian H; Yang H; Deng Z; Wang Z; Li H; Wen X; Xiao S; Huang P; Dai C; Lu L; Zhou K; Chen S; Zhou Y; Ran P
    Respir Res; 2022 Oct; 23(1):298. PubMed ID: 36316732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved Ratio Impaired Spirometry in a Spirometry Database.
    Schwartz A; Arnold N; Skinner B; Simmering J; Eberlein M; Comellas AP; Fortis S
    Respir Care; 2021 Jan; 66(1):58-65. PubMed ID: 32873751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Medical Utilization of Smokers with Preserved Ratio Impaired Spirometry.
    Shin YY; Park S; Kim KJ; Rhee CK; Yoo KH; Jung KS; Lee JH
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2187-2194. PubMed ID: 37822330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.